Nakase, Masaaki
Yahagi, Kazuyuki
Horiuchi, Yu
Asami, Masahiko
Yuzawa, Hitomi
Komiyama, Kota
Tanaka, Jun
Aoki, Jiro
Tanabe, Kengo
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of dapagliflozin on ventricular repolarization in patients with heart failure with reduced ejection fraction
https://doi.org/10.1007/s00380-023-02298-x
Article History
Received: 18 April 2023
Accepted: 27 July 2023
First Online: 12 September 2023
Declarations
:
: Dr. Tanabe receives lecture fee from Astellas Pharma, Kowa Company, Mitsubishi Tanabe Pharma Corporation, Nihon Boehringer Ingelheim, and Ono pharmaceutical. Dr. Aoki receives lecture fee from Astellas Pharma, Kowa Company, Daiichi Sankyo Company, and Nihon Boehringer Ingelheim. Dr. Tanaka receives lecture fee from AstraZeneca, Daiichi Sankyo Company, and Nihon Boehringer Ingelheim. Dr. Komiyama receives lecture fee from Daiichi Sankyo Company and Kowa Company. Dr. Yuzawa receives lecture fee from Daiichi Sankyo Company. Dr. Yahagi receives lecture fee from Daiichi Sankyo Company, Nihon Boehringer Ingelheim, and Fukuda Denshi. Dr. Asami receives lecture fee from AstraZeneca, Astellas Pharma, Daiichi Sankyo Company, and Nihon Boehringer Ingelheim. Dr. Horiuchi receives lecture fee from AstraZeneca and Nihon Boehringer Ingelheim. The remaining author report no conflicts of interest.